1,1- and 1,2-disubstituted cyclopropane compounds
AssigneeLes Laboratories Servier
InventorsSolo Goldstein, Claude Guillonneau, Yves Charton, Brian Lockhart, Pierre Lestage
Life of this patent
Estimating the term…
Loading patent…
AssigneeLes Laboratories Servier
InventorsSolo Goldstein, Claude Guillonneau, Yves Charton, Brian Lockhart, Pierre Lestage
Estimating the term…
A compound selected from those of formula (I): wherein: p represents an integer of from 0 to 6 inclusive, n represents an integer of from 0 to 6 inclusive, R1, and R2 represent a group selected from hydrogen, alkyl, aryl and arylalkyl, or R1+R2 form together with nitrogen carrying them saturated, monocyclic, or bicyclic system, X represents a group selected from oxygen, sulphur, a group —CH═CH—, methylene, a group of formula —HC═N—O— and a group of formula —O—CH2—CH═CH—, in which groups oxygen is linked to Y of the compounds of formula (I), Y represents a group selected from aryl, heteroaryl, arylalkyl, heteroarylalkyl, —C(O)-A, and —C(S)-A, A represents a group selected from alkyl, aryl, heteroaryl, arylalkyl, heteroarylalkyl, and NR3R4 wherein R3, and R4 represent a group selected from hydrogen, alkyl, aryl, and arylalkyl, or R3+R4 form together with nitrogen carrying them monocyclic, or bicyclic (C3-C10) system, its isomers and addition salts thereof with a pharmaceutically-acceptable acid or base, and medicinal products containing the same which are useful as specific nicotinic ligand of α4β2 receptors.
A compound selected from those of formula (I):
Dependencies are inferred from the claim text.